Rush University Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Rush University Medical Center sits in the top decile of US sponsors by registered trial count (#112 of 15,742 sponsors by registered trial count).
Rush University Medical Center: 320 sponsored US clinical trials, 53 recruiting.
Rush University Medical Center sponsors 320 registered US clinical trials on ClinicalTrials.gov, 53 of them currently recruiting, and 206 completed. 42 of these trials are in Phase 3-4 (later-stage) and 41 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Total Knee Arthroplasty, with 3 trials.
Top-decile sponsor footprint
Rush University Medical Center ranks in the top decile of sponsors by registered trial count (#112 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
206 of 244 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
320 total, page 6 of 7
Use of a Novel Fibrin Sealant in Total Knee Arthroplasty
NCT01656759
Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation
NCT01778712
Lifestyle Improvement Through Food and Exercise (LIFE)Study
NCT01901952
Hub Cleansing to Prevent Hub Infection
NCT01563406
Eszopiclone for the Treatment of Posttraumatic Stress Disorder
NCT01605253
Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep
NCT01695863
Circadian Phase Assessments at Home
NCT01487252
Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection
NCT01373112
Effect of Ischemic Strokes on Recovery From Intracerebral Hemorrhages
NCT01417117
Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
NCT01373099
Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis
NCT02588872
Mind-Body Medicine and Ulcerative Colitis
NCT01491997
Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
NCT01296529
Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty
NCT01760863
Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging
NCT01336140
Combined Social Worker and Pharmacist Transitional Care Program
NCT01503554
Carbohydrate Consumption as a Factor in Aspart Dosing
NCT01333514
Risk Factors and Mechanisms for Persistent Postsurgical Pain After Total Knee Replacement
NCT01320150
Reducing Disparities in Late Life Depression and Metabolic Syndrome
NCT01428791
A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes
NCT01379274
Varenicline for Gait and Balance Impairment in Parkinson Disease
NCT01341080
Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy
NCT02058693
Endoscopic Size Assessment of Advanced Adenomatous Polyps
NCT02193646
Study With Aminophylline to Attenuate of the Side Effects of Regadenoson
NCT01250496
Dilute Betadine Lavage in the Prevention of Postoperative Infection
NCT01175044
Effect of Prophylactic Antibiotics on Intra-Operative Culture Results
NCT01174212
Coping Peer Intervention for Adherence
NCT01169883
Women's Walking Program
NCT01700894
Validation of Dyskinesia Rating Scales
NCT01071395
The Community United to Challenge Asthma
NCT01061424
The Community United to Challenge Asthma
NCT01065883
Enhanced Discharge Planning Program -- Prospective
NCT01378234
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
NCT00891436
Use of Knotless Suture for Closure of Total Hip and Knee Arthroplasties
NCT00834483
Interleukin (IL)-13 as a Marker in Pediatrics Asthma
NCT00968305
Mindfulness-Based Approaches to Insomnia
NCT00768781
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
NCT00775606
Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine
NCT00737139
Self-Management in African Americans With Diabetes and Hypertension
NCT01244152
Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
NCT00591227
Sleep Length and Circadian Regulation in Humans
NCT00843843
Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
NCT00559819
Safety and Effectiveness Study of a Fiber Supplement for Weight Loss
NCT00613600
Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging
NCT00606138
Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
NCT00832585
Mind/Body Medicine and IBD Flare-Up
NCT00568256
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints
NCT00597376
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
NCT01155492
Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
NCT00682448
The Effects of Specialized Footwear in Osteoarthritis
NCT01597830
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 25 |
| Phase 3 | 6 |
| Phase 4 | 36 |
Therapeutic Areas
What is open in the Rush University Medical Center pipeline
53 recruiting of 320 indexed (17% open); 206 completed (64%).
Phase mix: 42 late (III/IV) vs 41 early (I/II) (balanced across stages).
Top condition: Total Knee Arthroplasty (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rush University Medical Center: open-pipeline peers nationwide
Peers matched on 320 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Rush University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 320 trials (± recruiting share)
- Jonsson Comprehensive Cancer Center · 321 trials · 19% recruiting
- University of Arkansas · 318 trials · 12% recruiting
- Allergan · 314 trials · 0% recruiting
- Genentech · 332 trials · 7% recruiting
Sponsors near 17% open enrollment (± trial volume)
- OHSU Knight Cancer Institute · 17% recruiting · 211 trials
- Massachusetts General Hospital · 17% recruiting · 2,032 trials
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
Related
What to do with this Rush University Medical Center page
320 registered trials is a research-attention snapshot, not an endorsement of Rush University Medical Center or any single study.
- 53 of Rush University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Total Knee Arthroplasty is the condition Rush University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Total Knee Arthroplasty trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rush University Medical Center pipeline card: 320 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.